ABBV vs AMZN
AbbVie Inc. vs Amazon.com, Inc.
ABBV
AbbVie Inc.
$208.05-2.05%
AMZN
Amazon.com, Inc.
$238.38+2.02%
Key Metrics Comparison
| ABBV | Metric | AMZN |
|---|---|---|
| $208.05 | Price | $238.38 |
| $367.87B | Market Cap | $2.56TBetter |
| 87.78 | P/E Ratio | 33.25Better |
| $2.37 | EPS | $7.17Better |
| -2.05% | Day Change | +2.02%Better |
| $244.81 | 52W High | $258.60 |
| $168.54 | 52W Low | $165.29 |
| 3,026,750 | Volume | 56,515,959Better |
| 7,156,652 | Avg Volume | 51,022,547Better |
About AbbVie Inc.
Healthcare | Drug Manufacturers - General
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...
About Amazon.com, Inc.
Consumer Cyclical | Specialty Retail
Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). Its products offered through its store...